DEA Considers Rescheduling Psilocybin

The DEA is considering reclassifying psilocybin, paving the way for broader medicinal use. Dr. Sunil Aggarwal has made significant progress in advocating for this change. #DEA #Psilocybin #MedicalResearch 🍄💊